These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3252291)

  • 1. [The clinical and roentgenologic picture of pulmonary changes in systemic sclerosis].
    Presetnik M; Music E; Rozman B
    Plucne Bolesti; 1988; 40(3-4):118-20. PubMed ID: 3252291
    [No Abstract]   [Full Text] [Related]  

  • 2. Shrinking lung syndrome in systemic sclerosis.
    Scirè CA; Caporali R; Zanierato M; Mojoli F; Braschi A; Montecucco C
    Arthritis Rheum; 2003 Oct; 48(10):2999-3000. PubMed ID: 14558114
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-breath pulmonary diffusing capacity. Reference values and application in connective tissue diseases and in various lung diseases.
    Salorinne Y
    Scand J Respir Dis Suppl; 1976; 96():1-84. PubMed ID: 1076826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional cardio-respiratory aspects of scleroderma].
    Morpurgo M; Rampulla C; Beulcke G; Casaccia M; Finardi G; Venco A
    Schweiz Med Wochenschr; 1972 Apr; 102(17):605-11. PubMed ID: 5021874
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pulmonary involvement in scleroderma assessed with high-resolution computerized tomography and functional tests].
    Dellafiore L; Colombo B; Del Sante M; Farina D; Zanoni C; Amaducci S; Beulcke G
    Radiol Med; 1994 May; 87(5):608-13. PubMed ID: 8008890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic sclerosis complicated by diffuse alveolar hemorrhage.
    Chaer RA; Massad MG; Evans A; Olopade C; Varga J
    Med Sci Monit; 2001; 7(5):1013-5. PubMed ID: 11535951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary manifestations of scleroderma].
    Cruchaud A
    Poumon Coeur; 1973; 29(3):311-8. PubMed ID: 4595705
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid onset of lung involvement in progressive systemic sclerosis.
    Bettmann MA; Kantrowitz F
    Chest; 1979 Apr; 75(4):509-10. PubMed ID: 446143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung function in relation to radiographic changes in asbestos workers.
    Zedda S; Aresini G; Ghezzi I; Sartorelli E
    Respiration; 1973; 30(2):132-40. PubMed ID: 4721903
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pulmonary involvement in scleroderma].
    Tabacu E; Duţu S; Stoicescu P
    Pneumoftiziologia; 1992; 41(2-3):141-4. PubMed ID: 1342812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung impairment in scleroderma.
    Piorunek T; Kuznar-Kaminska B; Cofta S; Batura-Gabryel H; Poplawski D; Majewski D; Puszczewicz M; Wysocka E
    Adv Exp Med Biol; 2013; 755():149-54. PubMed ID: 22826062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital ulcers predict a worse disease course in patients with systemic sclerosis.
    Mihai C; Landewé R; van der Heijde D; Walker UA; Constantin PI; Gherghe AM; Ionescu R; Rednic S; Allanore Y; Avouac J; Czirják L; Hachulla E; Riemekasten G; Cozzi F; Airò P; Cutolo M; Mueller-Ladner U; Matucci-Cerinic M;
    Ann Rheum Dis; 2016 Apr; 75(4):681-6. PubMed ID: 25688073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Honeycomb lungs].
    Souquet R; Batime J; Kermarec J; Haguenauer G; Pernod J
    Lyon Med; 1971 Oct; 226(15):267-78. PubMed ID: 4941871
    [No Abstract]   [Full Text] [Related]  

  • 15. Diffusing capacity of the lung and nifedipine in systemic sclerosis.
    Sfikakis PP; Kyriakidis M; Vergos C; Papazoglou S; Georgiakodis F; Toutouzas P; Sfikakis P
    Arthritis Rheum; 1990 Nov; 33(11):1634-9. PubMed ID: 2242061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redistribution of pulmonary blood flow in interstitial lung diseases: the chest radiograph as a physiologic tool.
    Thomas HM; Austin JH; Yount BG; Enson Y
    Bull Eur Physiopathol Respir; 1979; 15(5):1079-89. PubMed ID: 508975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Destructive disease of the lungs with the formation of gigantic cysts and cavities in systemic scleroderma].
    Guseva NG; Shanina VA; Denisov LN; Savarovskii AI
    Ter Arkh; 1972 Nov; 44(11):43-8. PubMed ID: 4666029
    [No Abstract]   [Full Text] [Related]  

  • 18. Pleuropulmonary manifestations of collagen diseases.
    Delanote GJ; Heps S; Baert AL; Dequeker J
    J Belge Radiol; 1974; 57(5):337-46. PubMed ID: 4154931
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration?
    Johnson DA; Drane WE; Curran J; Cattau EL; Ciarleglio C; Khan A; Cotelingam J; Benjamin SB
    Arch Intern Med; 1989 Mar; 149(3):589-93. PubMed ID: 2919934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung involvement in systemic sclerosis.
    Silver RM; Miller KS
    Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.